ArticleJournal of nanobiotechnology2021

Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity.

Kai-Wen Ho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.